 Financial Post | Valeant bets on anti-aging boom with Medicis takeover bid Financial Post MONTREAL — With 15 acquisition offers this year alone, Valeant Pharmaceuticals International Inc. chief executive J. Michael Pearson looks like a wheeler-dealer in a hurry. But his latest bet, a $2.6-billion cash bid for U.S.-based Medicis ... |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.